CTSA Program

  • CLIC Virtual Tour artwork - laptop with documents, video icons etc floating around it

    The CLIC Virtual Tour is designed to give everyone involved with the CTSA Program, regardless of in what capacity, an overview of what CLIC provides and how to make it work for you. Think: a virtual ‘walk-through’ of new website resources, ways to communicate and guidance on how to access. It will be a multipart series, including live question and answer sessions. Videos will be released on the

  • University Of Pennsylvania Logo
    University Of Pennsylvania

    KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Melissa Barker-Haliski, PhD from the University of Washington, hosted by the University of Pennsylvania will present her research on the "Impact of Chronic Seizures on Cognitive and Neuropsychiatric Comorbidities in AD-Associated Preclinical Models."

  • -
    Harvard Medical School

    KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Heather Watchel, MD from the University of Pennsylvania, hosted by the Harvard Medical School will present her research on “Circulating microRNA Signatures in Primary Hyperparathyroidism.”

  • MUSC
    Medical University Of South Carolina

    KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Aaron Seaman, PhD from the University of Iowa, hosted by the Medical University of South Carolina will present his research on "Identifying the Care Delivery Needs and Outcomes for Rural Head and Neck Cancer Survivorship." Survivors of head and neck cancer (HNC

  • The CTSA Program strives to deliver scientific and system changes that solve the many outstanding problems limiting the efficiency, effectiveness, and reach of clinical translational research, and thus get more treatments to more patients more quickly across the country. As the largest clinical translational science network and as an exemplar to team science, NCATS envisions the CTSA Program

  • University of Miami CTSI
    University Of Miami School Of Medicine
    KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Chandylen Nightingale, PhD, MPH from the Wake Forest School of Medicine, hosted by the University of Miami School of Medicine will present her research on “Examining Capacity in Community Oncology and Moving the Needle to Improve Supportive Care Delivery for
  • -
    University Of North Carolina Chapel Hill

    Andrea Knittel's research focuses on the effects of the criminal legal system on women's reproductive transitions. This virtual presentation will highlight the methods and strategies used in recruiting women who have experienced incarceration and the people from their personal social networks. The Inclusive Science Program (ISP) at the North Carolina Translational and Clinical Sciences (NC TraCS)

  • We have arrived in 2021, hopeful for scientific advances to curb this pandemic once and for all. Our preparedness and readiness have been crucial in the development and implementation of several clinical trials leading the way in identifying safe and effective therapies and diagnostics for COVID-19. During this process we have witnessed incredible levels of innovation and adaptation, from the N3C

  • N3C is hosting an Open House to engage CTSA members, newcomers, and the wider translational research community. The event will be kicked off with a one-hour symposium that includes opening remarks from N3C leadership, followed by a PI/Clinician Testimonial with Dr. David Ellison of OCTRI, an N3C Tutorial on how to get involved, a demonstration of the N3C Data Enclave, and flash talks from the

  • University of Pittsburgh
    University Of Pittsburgh At Pittsburgh
    KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of CTSA Visiting Scholar Program. Marisa McGinley, DO MSC, from the Clinical and Translational Science Collaborative of Cleveland, hosted by the Clinical and Translational Science Institute at the University of Pittsburgh will present her research on "Learning Technology for Multiple Sclerosis Care
  • We have now completed a full cycle of virtual CTSA Program meetings where we had the opportunity to share each other’s presence – from a healthy and safe distance. Remarkably, during such a challenging year, we have managed to remain engaged and maintain quality and participation in our meetings under these “new normal” virtual gatherings. Summarizing a meeting with so many highlights is no easy

  • -
    Harvard Medical School
    Lecture: CTSA Visiting Scholars KL2 awardees from clinical and translational science centers (CTSA) present virtual lectures as part of CTSA Visiting Scholars. Ashaunta Anderson, MD, University of Southern California, will present her research on "Cultural Pride Reinforcement for Early School Readiness (CPR4ESR): Pilot of a Clinic-Based Literacy Program to Promote Cultural Pride and School
  • Center for Data to Health

    N3C Domain Teams enable researchers with shared interests to analyze data within the N3C Data Enclave and collaborate more efficiently in a team science environment.

  • Stanford Center for Clinical and Translational Research (Spectrum)
    Stanford University
    This 10-session course introduces the basics of clinical research design, including biostatistics, design of diagnostic and predictive test studies, and required/desired elements of clinical trial protocols. Participants will also gain an understanding of the regulatory aspects of clinical research conduct and oversight, Good Clinical Practice (GCP), and ethical dimensions of clinical research
  • Listen to the latest Bioinformatics & Beyond podcast hosted by Leo Elworth. Dr. Melissa Haendel discusses how the N3C organization she co-leads and co-founded has led the way in integrating COVID-19 clinical data to aid research efforts. She discusses how the creation of synthetic clinical data also has the potential to help COVID-19 researchers. Further topics include the current status of
  • Anita Walden (CD2H/N3C), Nicole Garbarini (NCATS), Heidi Spratt (UTMB), Charisse Madlock-Brown (UTHSC), and Sally Hodder (WVU) give an overview and update on the status of the N3C and governance policy, with a focus on Clinical Domain Teams, IDeA-CTR partnership, and engagement. N3C overview and status updates Data agreements; status and process Domain Teams, value, and opportunities Social
  • The Foundations of Biomedical Data Science virtual seminar series is an exciting and topical set of regularly scheduled, weekly, webinar presentations covering the basics of data management, representation, computation, statistical inference, data modeling, & other topics relevant to “big data” biomedicine. The seminar series provides fundamental topic introductions suitable for individuals at all

  • As COVID-19 continues as a top priority at all levels of our research enterprise, finding strategies to contain the spread of the virus and better treat the disease and its complications remains paramount. RADx-UP is an NIH initiative to support the development of community-engaged projects across the United States to assess and expand COVID-19 testing for underserved and/or vulnerable populations

  • Working towards a cure for HIV requires many things – tenacity, determination, and collaboration. In the early 1980s, when a patient received a diagnosis of HIV (human immunodeficiency virus), the individual was often told to get their affairs in order. Their life expectancy could range from just a few weeks to a few months. Today, a person may receive the same diagnosis and live for several more

  • Jennifer Moss, Ph.D., an assistant professor of family and community medicine at Penn State College of Medicine, recently published research about the cancer screening rates of older Americans. She reported that many older Americans are receiving cancer screenings past recommended ages – a situation called overscreening. This study was partially supported by Penn State Clinical and Translational
  • Center for Data to Health

    Background: America’s grim COVID-19 statistics tell a story of human suffering and loss on an epic scale. But there is more to that story than scary numbers—a hopeful plot twist in which patients’ health data are transformed into knowledge that guides our way out of the crisis. The National COVID Cohort Collaborative (N3C) is a new effort to collect, harmonize, and collaboratively analyze

  • From the early days of the COVID-19 pandemic, epidemiologist Melissa Haendel knew that the United States was going to have a data problem. There didn’t seem to be a national strategy to control the virus, and cases were springing up in sporadic hotspots around the country. With such a patchwork response, nationwide information about the people who got sick would probably be hard to come by. Other

  • As the pandemic wears on, doctors are learning more about how to better care for patients with COVID-19, but there is still so much to learn. Moreover, the long-term effects of the disease are unknown. So the NIH and its National Center for Advancing Translational Sciences (NCATS) have launched a National COVID Cohort Collaborative (N3C) to collect electronic health record (EHR) data from partners

  • Pennsylvania State Univ Hershey Med Ctr

    Penn State Clinical and Translational Science Institute has led University-wide efforts to transform clinical and translational science since 2007. It promotes interdisciplinary collaboration and provides essential research infrastructure. This research infrastructure allows Penn State to quickly address and adjust to current events, high priority translational research topics and, most recently

  • As fall begins and with multiple promising treatment approaches to improve outcomes in COVID-19 coming to light, it is of critical need to rapidly implement trials to further study and confirm (or reject) these preliminary findings through well-designed randomized controlled clinical trials. As such, the resources, infrastructure and expertise throughout the CTSA consortium – including our Trial

  • Sergio Aguilar-Gaxiola, director of the UC Davis Center for Reducing Health Disparities, has received a prestigious award from the Mexican government for his work in advocating for the rights of Mexican nationals in the United States. The recognition – known as the Ohtli Award – is the highest honor granted by the Mexican government to individuals who have dedicated their lives to improving the
  • “I wish that I could fly Into the sky So very high Just like a dragonfly I'd fly above the trees Over the seas in all degrees To anywhere I please Oh I want to get away I want to fly away Yeah yeah yeah” - Lenny Kravitz
  • As the COVID-19 pandemic continues to rampage across the globe and now some nations previously lauded for their infection control practice are seeing a resurgence, along with emerging science suggesting not only a very low infectious dose, but also efficient asymptomatic transmission, the focus on COVID interventions both treatment and prevention is heating up. Across the United States, several

  • Center for Data to Health

    Guidance for partners and collaborators to communicate about N3C to internal and external audiences. This document contains approved messaging from NCATS to assist with press releases and other outreach efforts.

  • During the past several months (there are times when the weeks feel like days and then others when the days feel like months), we have been working to address the ongoing COVID-19 pandemic by creating a centralized, secure, cloud-based clinical data portal. To this end, NCATS recently launched the National COVID Cohort Collaborative (N3C) to build a centralized national data resource that focuses